MediWound (MDWD) Non-Current Assets (2016 - 2025)
MediWound's (MDWD) quarterly Non-Current Assets came in at $26.3 million in Q4 2025, up 23.24% year-on-year from $21.3 million in Q4 2024, and up 5.63% quarter-over-quarter from $24.9 million in Q3 2025.
MediWound (MDWD) Non-Current Assets (2016 - 2025) Analysis & Trends
MediWound's Non-Current Assets history runs 10 years deep, the most recent figure standing at $26.3 million for Q4 2025.
- On a quarterly basis, Non-Current Assets rose 23.24% year-over-year to $26.3 million in Q4 2025; TTM through Dec 2025 was $26.3 million, a 23.24% increase from a year earlier, with the FY2025 full-year figure at $26.3 million, up 23.24% from the prior year.
- Non-Current Assets climbed to $26.3 million in Q4 2025 per MDWD's latest filing, from $24.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $26.3 million in Q4 2025 and bottomed at $4.1 million in Q3 2022.
- The 5-year median for Non-Current Assets is $10.0 million (2023), against an average of $12.8 million.
- Across the five-year window, Non-Current Assets fell 12.85% in 2022 and surged 301.44% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $4.8 million in 2021, then dropped by 12.85% to $4.2 million in 2022, then jumped by 301.44% to $16.8 million in 2023, then advanced by 27.25% to $21.3 million in 2024, then rose by 23.24% to $26.3 million in 2025.
- Per Business Quant, the three latest MDWD Non-Current Assets figures stand at $26.3 million (Q4 2025), $24.9 million (Q3 2025), and $23.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | 26.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.29 Mn |
| Sep 30, 2025 | 24.89 Mn |
| Jun 30, 2025 | 23.92 Mn |
| Mar 31, 2025 | 21.99 Mn |
| Dec 31, 2024 | 21.33 Mn |
| Sep 30, 2024 | 20.85 Mn |
| Jun 30, 2024 | 19.98 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 16.76 Mn |
| Sep 30, 2023 | 13.77 Mn |
| Jun 30, 2023 | 6.31 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 4.18 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 4.41 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | 4.50 Mn |
| Jun 30, 2021 | 4.68 Mn |
| Mar 31, 2021 | 4.79 Mn |